STAT3 and neoplasm: In the context of cancer disease, PTPRD is absent or inactive in a variety of human tumor types, playing a tumor suppressor role linked with the downregulation of STAT3 activity (Lin et al., 2021; Ortiz et al., 2014; Solomon et al., 2008; Veeriah et al., 2009).